TNFR2 promotes Treg-mediated recovery from neuropathic pain across sexes

Roman Fischer, Maksim Sendetski, Tania del Rivero, George F. Martinez, Valerie Bracchi‐Ricard, Kathryn A. Swanson, Elizabeth Pruzinsky, Niky Delguercio, Michael J. Rosalino, Tanja Padutsch,

Proceedings of the National Academy of Sciences · 2019 · 71 citations · 31 references

DOIFull text

Open access

Concepts

Abstract

Significance Tumor necrosis factor (TNF) is a cytokine that induces signaling via two receptors, TNFR1 and TNFR2. TNF signaling via TNFR1 contributes to development and maintenance of neuropathic pain. Here, we show that TNFR2 is essential for recovery from neuropathic pain across sexes. Treatment of male and female neuropathic mice with a TNFR2 agonist resulted in long-lasting recovery from neuropathic pain. We identified Tregs as the cellular mediator of the analgesic effect of TNFR2. Indeed, TNFR2 agonist administration alleviated peripheral and central inflammation and promoted neuroprotection in a Treg-dependent manner, indicating that TNFR2-dependent modulation of immunity is neuroprotective. We therefore argue that TNFR2 agonists might be a class of nonopioid drugs that can promote long-lasting pain recovery in males and females.

References

31